THYROCARE — Thyrocare Technologies Balance Sheet
0.000.00%
- IN₹26.27bn
- IN₹24.57bn
- IN₹6.87bn
- 98
- 47
- 99
- 96
Annual balance sheet for Thyrocare Technologies, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | 2025 March 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IAS | IAS | IAS | IAS | IAS |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 1,202 | 1,391 | 1,508 | 1,766 | 1,918 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 514 | 953 | 894 | 468 | 742 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 2,381 | 2,700 | 2,729 | 2,785 | 3,377 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 1,601 | 1,868 | 1,944 | 2,037 | 1,983 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 5,458 | 6,077 | 6,327 | 6,439 | 6,928 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 951 | 645 | 771 | 905 | 1,218 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Funded Status | |||||
| Total Liabilities | 1,185 | 811 | 984 | 1,171 | 1,460 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| ESOP Debt Guarantee | |||||
| Other Equity | |||||
| Total Equity | 4,273 | 5,266 | 5,343 | 5,268 | 5,468 |
| Total Liabilities & Shareholders' Equity | 5,458 | 6,077 | 6,327 | 6,439 | 6,928 |
| Total Common Shares Outstanding |